The impact of biology on the treatment of secondary AML.

Gojo, I

The impact of biology on the treatment of secondary AML. [electronic resource] - Cancer treatment and research 2001 - 231-55 p. digital

Publication Type: Journal Article; Review

0927-3042

10.1007/978-1-4615-1463-3_12 doi


Acute Disease
Angiogenesis Inhibitors--therapeutic use
Animals
Antineoplastic Agents--therapeutic use
Antineoplastic Agents, Alkylating--adverse effects
Chromosome Deletion
Chromosomes, Human, Pair 11--genetics
Chromosomes, Human, Pair 7--genetics
DNA Methylation
DNA-Binding Proteins--genetics
Enzyme Inhibitors--adverse effects
Forecasting
Genes, Tumor Suppressor
Hematopoietic Stem Cells--drug effects
Histone Deacetylase Inhibitors
Histone-Lysine N-Methyltransferase
Humans
Leukemia, Experimental--etiology
Leukemia, Myeloid--chemically induced
Leukemia, Radiation-Induced--pathology
Mice
Mice, Inbred NOD
Mice, SCID
Myeloid-Lymphoid Leukemia Protein
Neoplasm Proteins--antagonists & inhibitors
Neoplasms--drug therapy
Neoplasms, Second Primary--chemically induced
Neoplastic Stem Cells--drug effects
Neovascularization, Pathologic--drug therapy
Oncogene Proteins, Fusion--genetics
Proto-Oncogenes
Stromal Cells--pathology
Topoisomerase II Inhibitors
Transcription Factors
Translocation, Genetic
Xenograft Model Antitumor Assays